Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Cameli and Elena Bargagli.
Connection Strength
3.442
-
High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool? Intern Emerg Med. 2021 08; 16(5):1329-1330.
Score: 0.941
-
Omalizumab treatment in Samter's triad: case series and review of the literature. Eur Rev Med Pharmacol Sci. 2019 Sep; 23(18):8124-8129.
Score: 0.840
-
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes. J Med Virol. 2021 02; 93(2):657.
Score: 0.225
-
Serum KL-6 concentrations as a novel biomarker of severe COVID-19. J Med Virol. 2020 10; 92(10):2216-2220.
Score: 0.222
-
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases. Panminerva Med. 2020 Jun; 62(2):109-115.
Score: 0.211
-
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? Medicine (Baltimore). 2019 Jun; 98(26):e16086.
Score: 0.206
-
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? Respir Med Case Rep. 2019; 27:100843.
Score: 0.205
-
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6. Dis Markers. 2019; 2019:8565423.
Score: 0.203
-
Prognostic bioindicators in severe COVID-19 patients. Cytokine. 2021 05; 141:155455.
Score: 0.058
-
Serial KL-6 measurements in COVID-19 patients. Intern Emerg Med. 2021 09; 16(6):1541-1545.
Score: 0.058
-
Peripheral biomarkers' panel for severe COVID-19 patients. J Med Virol. 2021 03; 93(3):1230-1232.
Score: 0.057
-
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients. Ultrasound Med Biol. 2021 01; 47(1):19-24.
Score: 0.056
-
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis. 2021 02; 80(2):e14.
Score: 0.055
-
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients. Minerva Med. 2021 06; 112(3):423-426.
Score: 0.055
-
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib. Respir Investig. 2019 May; 57(3):290-291.
Score: 0.051